Leonard Matthew J
SEC CIK 1773152 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | Dir | 11.2K | — | $840.7K | 6 | 2023-08-21 | 2026-05-21 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
| 14 | Leonard Matthew J | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 21:08 | 2026-05-21 | ANIP | ANI PHARMACEUTICALS INC | Leonard Matthew J | Dir | A - Grant | $0.00 | +4,357 | 11.2K | +63% | $0 | |
| 2025-08-26 | 2025-08-25 | ANIP | ANI PHARMACEUTICALS INC | Leonard Matthew J | Dir | S - Sale | $90.62 | -2,528 | 6,864 | -27% | -$229.1K | |
| 2025-08-18 | 2025-08-18 | ANIP | ANI PHARMACEUTICALS INC | Leonard Matthew J | Dir | S - Sale | $88.17 | -6,937 | 9,392 | -42% | -$611.6K | |
| 2025-05-27 | 2025-05-22 | ANIP | ANI PHARMACEUTICALS INC | Leonard Matthew J | Dir | A - Grant | $0.00 | +4,336 | 16.3K | +36% | $0 | |
| 2024-05-23 | 2024-05-21 | ANIP | ANI PHARMACEUTICALS INC | Leonard Matthew J | Dir | A - Grant | $0.00 | +4,410 | 12.0K | +58% | $0 | |
| 2023-08-23 | 2023-08-21 | ANIP | ANI PHARMACEUTICALS INC | Leonard Matthew J | Dir | A - Grant | $0.00 | +7,583 | 7,583 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations